Metraipolis › archive › dc_4872134b442d

Efficacy and safety of cadonilimab for malignant solid tumor treatment: a systematic review and meta-analysis — Europe PMC PMID:42292353

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42292353
DOI
10.3389/fimmu.2026.1851837
License (as archived)
solo-consultazione
Archived
2026-11-01T04:07:40.734Z
SHA-256 of the archived text
16ab12fd2f294ef20d0b4d95bc2da7a049015a348875b366bad963d3e4c4d0be
Stable URL of this page
https://metraipolis.com/documento/dc_4872134b442d

How to cite

Efficacy and safety of cadonilimab for malignant solid tumor treatment: a systematic review and meta-analysis — Europe PMC PMID:42292353 — Europe PMC (en), https://europepmc.org/article/MED/42292353 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4872134b442d (Metraipolis archive dc_4872134b442d, sha256 16ab12fd2f294ef20d0b4d95bc2da7a049015a348875b366bad963d3e4c4d0be)
BibTeX
@misc{dc4872134b442d,
  title = {Efficacy and safety of cadonilimab for malignant solid tumor treatment: a systematic review and meta-analysis — Europe PMC PMID:42292353},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42292353},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4872134b442d; sha256 16ab12fd2f294ef20d0b4d95bc2da7a049015a348875b366bad963d3e4c4d0be},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42292353. Agents can read the archived copy with the MCP tool read_document.